Navigation Links
New gene scanning technology marks a major advance in disease research

Gene scanning techniques developed by Professor Ian Day and colleagues at the University of Southampton are set to have a major impact on healthcare in the future.

One of two gene mutation scanning techniques devised by Professor Day and his team in the Human Genetics Division of the University's School of Medicine has been successfully applied to search for rare genetic mutations in the population at large.

Their method, called meltMADGE, which combines thermal ramp electrophoresis with microplate array diagonal gel electrophoresis (MADGE), enables significantly higher levels of scanning at a fraction of the cost.

Using the Southampton technique a network of British medical researchers from the Universities of Southampton, Bristol and University College London, funded by the UK's Medical Research Council, British Heart Foundation and Department of Health, studied a gene which affects blood cholesterol levels. In analyses of nearly 10,000 middle-aged individuals, they found some rare mutations associated with very high cholesterol, some with moderately high cholesterol and some with no effect.

This is the first time that it has been possible to find out whether there may be unknown rare genetic variations in the population which may cause mild forms of a particular disease or feature in just one or two individuals, or may even protect them against disease.

Professor Day commented: 'This development enables us to look at the whole population and find rare and "special" individuals with gene changes which may have either mild, moderate, severe or protective disease effects, a bit like the medical equivalent of finding a needle in a haystack.

'While this approach is currently at the research level, in the future it could lead to a very personalised genetic profile of a whole range of genes relevant to lifestyle, health and drug prescribing, leading to more personalised medicine and screening.'

Professor Day's group is using combinations of meltMADGE and a second technology called endo VII MADGE to explore variations in the whole population of disease genes relevant to growth, obesity and cardiovascular disease.


'"/>

Source:Cold Spring Harbor Laboratory


Related biology news :

1. Novel technology detects human DNA mutations
2. Novel antiviral technology inhibits RSV infection in mice
3. The BIOS Initiative - open source biotechnology is born
4. Revolutionary nanotechnology illuminates brain cells at work
5. Study: homemade gene expression technology unreliable
6. First technology to remove prions that cause vCJD from blood launched
7. Integration of Agilents MS technology, Proteome Systems software to help scientists in proteomics research
8. Agilent Technologies new genome analysis technology set to accelerate Australia fight against mesothelioma
9. Recombinant DNA technology may enable oral, rather than injectable, delivery of protein drugs
10. First production of human monoclonal antibodies in chicken eggs published in Nature Biotechnology
11. Vietnam war technology could aid elephant conservation
Post Your Comments:
*Name:
*Comment:
*Email:


(Date:10/5/2018)... DIEGO (PRWEB) , ... October 04, 2018 , ... Nothing ... cooking classes have become so popular. , Cooking appeals to companies because ... as group interaction, team cohesion, collaboration and decision-making skills. It’s also appealing in ...
(Date:10/2/2018)... ... October 02, 2018 , ... Stuart is a fun-loving eight-year-old Labrador retriever. Like many ... owner, Cynthia, “He loves playing ball so much that whenever anyone comes to our door, ... a game of fetch.” In early 2017, Stuart began limping and eventually could no ...
(Date:10/1/2018)... ... 2018 , ... NanoValent Pharmaceuticals, Inc ., (NanoValent) a ... today announced the National Institute of Health (NIH) Small Business ... for two separate grants. These two grants will allow NanoValent to advance two ...
Breaking Biology News(10 mins):
(Date:10/2/2018)... ... October 02, 2018 , ... ... R&D, today announced a new out-of-the-box integration of the Genedata Bioprocess ... pharmaceutical and laboratory equipment supplier. This enables the automatic import of raw ...
(Date:9/28/2018)... ... September 28, 2018 , ... GlycoMark®, Inc. ... availability of the GlycoMark test, the only FDA-cleared blood test specific to detecting ... will promote and offer the GlycoMark test to its network of physicians through ...
(Date:9/27/2018)... ... September 26, 2018 , ... Nvision Biomedical Technologies ... Screw System today at the North American Spine Society (NASS) Annual Meeting, held ... focus Pedicle Screw System, which received clearance from the U.S. Food and Drug ...
(Date:9/22/2018)... ... September 20, 2018 , ... Catalent Pharma ... drugs, biologics and consumer health products, today announced that it will be co-hosting ... in Modern Pharmaceutical Development,”. The one-day event is to be held at the ...
Breaking Biology Technology: